CESAR: Center for Substance Abuse Research

What's New

CESAR FAX Bound and Indexed Annual Volume Now Available

 January 2014

Have all of the 2013 CESAR FAX issues at your fingertips with this bound volume, indexed by issue number and subject area. To purchase a copy, please mail the order form along with a purchase order or check for $10 to CESAR.

CESAR Pilots New Community Drug Early Warning System (CDEWS)

September 2013

Emerging drugs of abuse in communities can be rapidly identified by an innovative urine testing system, according to the results of a recently released ONDCP-funded pilot study of the Community Drug Early Warning System (CDEWS). CDEWS is designed to detect emerging drugs by re-testing urine specimens collected for traditional criminal justice system (CJS) drug testing programs, and examining them for emerging drugs of abuse, such as synthetic cannabinoids (SC). The pilot study tested urine specimens from five criminal justice system (CJS) populations in Washington, DC; Prince George’s County, Maryland; and Chesterfield, Virginia for an expanded panel of more than 30 prescription and illicit drugs, including 12 SC metabolites. SC metabolites were detected in all of the populations studied.

A copy of the full report can be found on the ONDCP website. The press release from the University of Maryland can be found online at http://www.umdrightnow.umd.edu/news/innovative-testing-program-detects-emerging-drugs and a short video of CESAR's Director, Dr. Eric Wish, discussing the study is available at http://youtu.be/UqmiI8afxEY.


CESAR FAX Special Series on Synthetic Cannabinoids Updated

October 2013

Stay on top of the most recent research and survey results regarding synthetic cannabinoids with this updated compilation of CESAR FAX issues on the topic.


CESAR FAX Special Series on Buprenorphine Updated

February 2013

While research indicates that buprenorphine is an effective drug for treating opioid dependence, we feel that the potential for its nonmedical use and related unintended consequences may be going unnoticed. This series of publications on buprenorphine was designed to highlight several indicators of the increased availability, diversion, and misuse of buprenorphine.